Clinical Trial Update: Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of SEROQUEL XR (quetiapine extended-release) in adults with acute schizophrenia; results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SEROQUEL XR (Quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2013-01-08